Cargando…
Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
SIMPLE SUMMARY: Only about 15% of intrahepatic cholangiocarcinoma (ICC) patients meet the criteria for resection at the time of diagnosis. For patients with advanced and/or metastatic disease, the development of novel therapeutic strategies is urgently needed. The aim of our study was to identify po...
Autores principales: | Xiao, Yao, Zhang, Baoluhe, Cloyd, Jordan M., Alaimo, Laura, Xu, Gang, Du, Shunda, Mao, Yilei, Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265136/ https://www.ncbi.nlm.nih.gov/pubmed/35805055 http://dx.doi.org/10.3390/cancers14133284 |
Ejemplares similares
-
Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020) -
Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
por: Beal, Eliza W., et al.
Publicado: (2020) -
Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022) -
Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
por: Jin, Bao, et al.
Publicado: (2023) -
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)